POLE and neoplasm: Other approaches under investigation include CAR-macrophages (NCT04660929), tumor-infiltrating lymphocyte therapy in MMRd and POLE-mutant tumors (NCT06481592), NK cell therapies, and TCR-engineered T cells (33, 48, 49).